High-risk human papillomavirus testing for underscreened populations: cost-effectiveness and affordability in three country settings

High-risk human papillomavirus testing for underscreened populations: cost-effectiveness and affordability in three country settings

Abstract Background The high-risk human papillomavirus (hrHPV)-based screening recommended by the World Health Organization is expected to lead to worldwide reduction of the cervical cancer burden, but the countries burdened most by cervical cancer also struggle with the costs of transitioning to th...

Full description

Saved in:
Bibliographic Details
Main Authors: Marat Sultanov, Geertruida H. de Bock, Jaap A.R. Koot, Janine de Zeeuw, Marcel J.W. Greuter, Fengming Pan, Jelle Stekelenburg, Jogchum J. Beltman, Marlieke de Fouw, Carolyn Nakisige, Johnblack K. Kabukye, Ezra Anecho, Naheed Nazrul, Mosamat U. Kulsum, Aminur Rahman, Marek Majdan, Juliana Melichová, Jaroslava Sokolová, Jurjen van der Schans
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Public Health
Subjects:
Cervical cancer
Screening
Cost-effectiveness
Budget impact
High-risk human papillomavirus
Economic evaluation
Online Access:https://doi.org/10.1186/s12889-025-23791-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items